1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Expanding choice and access in contraception: an assessment of intrauterine contraception policies in low and middle-income countries

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Globally 214 million women of reproductive age in developing regions have unmet needs in modern contraceptives. Intrauterine contraception (IUC) is highly effective, has few medical contraindications, low discontinuation, and is a low cost modern contraceptive method. However, there is relatively low use of IUDs in LMICs. One reason for this may be policies that restrict IUD availability and use. This study assess national policies pertaining to IUD from a diverse set of countries.

          Methods

          Between December 2015 and February 2016, a 12-question survey pertaining to IUD policy was sent to WHO regional and country representatives.

          Results

          Sixty-nine surveys were used from countries through WHO regional offices. Among those surveyed, 87% ( n = 60) had policies pertaining to IUD use. Among them, 84% ( n = 58) reported that hormonal IUDs were available, but only 42% ( n = 29) had them in the public sector. Free IUDs in the public sector were available in 75% ( n = 52) of countries. For IUD promotion, 75% ( n = 52) of countries reported cooperation with NGOs, and 48% ( n = 33) received free devices from donors. Policy restrictions beyond the WHO guidelines existed in 15 countries and included restrictions to use for women who were nulliparous, adolescent, unmarried, or had multiple partners.

          Conclusions

          National policy is important in facilitating modern contraceptive uptake. While many countries who responded in the survey, have policies about IUD use in place, 16% still had none on IUD. Another gap identified was low availability of hormonal IUDs, especially in the public sector. Private sector remains untapped potential in expanding method choice by making IUDs available and accessible in developing countries. Most countries do have policy in place to facilitate IUD use, though there are still gaps in the accessibility of IUDs in many countries. Lastly there is a need to revisit restrictive policies that prevent IUD use for specific populations of women for whom IUDs can be beneficial in realizing their reproductive needs.

          Related collections

          Most cited references7

          • Record: found
          • Abstract: found
          • Article: not found

          Cost effectiveness of contraceptives in the United States.

          The study was conducted to estimate the relative cost effectiveness of contraceptives in the United States from a payer's perspective. A Markov model was constructed to simulate costs for 16 contraceptive methods and no method over a 5-year period. Failure rates, adverse event rates and resource utilization were derived from the literature. Sensitivity analyses were performed on costs and failure rates. Any contraceptive method is superior to "no method". The three least expensive methods were the copper-T intrauterine device (IUD) (US$647), vasectomy (US$713) and levonorgestrel (LNG)-20 intrauterine system (IUS) (US$930). Results were sensitive to the cost of contraceptive methods, the cost of an unintended pregnancy and plan disenrollment rates. The copper-T IUD, vasectomy and the LNG-20 IUS are the most cost-effective contraceptive methods available in the United States. Differences in method costs, the cost of an unintended pregnancy and time horizon are influential factors that determine the overall value of a contraceptive method.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The cost-effectiveness of long-acting reversible contraceptive methods in the UK: analysis based on a decision-analytic model developed for a National Institute for Health and Clinical Excellence (NICE) clinical practice guideline.

            Long-acting reversible contraceptive (LARC) methods are highly effective in preventing unintended pregnancies. However, their uptake is low in much of the developed world. This study aimed at assessing the cost-effectiveness of LARC methods from the British National Health Service (NHS) perspective. A decision-analytic model was constructed to estimate the relative cost-effectiveness of the copper intrauterine device (IUD), the levonorgestrel intrauterine system (LNG-IUS), the etonogestrel subdermal implant and the depot medroxyprogesterone acetate injection (DMPA). Comparisons with the combined oral contraceptive pill (COC) and female sterilization were also performed. Effectiveness data were derived from a systematic literature review. Costs were based on UK national sources and expert opinion. LARC methods dominated COC (i.e. they were more effective and less costly). Female sterilization dominated LARC methods beyond 5 years of contraceptive protection. DMPA and LNG-IUS were the least cost-effective LARC methods. The incremental cost-effectiveness ratio of implant (most effective LARC method) versus IUD (cheapest LARC method) was pound13 206 per unintended pregnancy averted for 1 year of use and decreased until implant dominated IUD in 15 years. Discontinuation was a key determinant of the cost-effectiveness of LARC methods. LARC methods are cost-effective from the British NHS perspective. Practices improving user satisfaction and continuation of LARC method use should be identified and promoted.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Worldwide use of intrauterine devices for contraception.

              The intrauterine device is the most widely used reversible method of contraception in the world today, particularly in developing countries where it is used by 14.5% of women of reproductive age. In the developed world, this percentage is only 7.6%. There are marked regional differences with the highest use in Eastern Asia and the lowest in North America. Such differences between regions and countries can be explained by a number of factors at the individual, service delivery, program and policy levels. The situation in seven countries is briefly described to illustrate this and to conclude that this method of contraception is largely underutilized in many parts of the world, where it could play a significant role in improving women's health.
                Bookmark

                Author and article information

                Contributors
                alimoa@who.int
                rcfolz@gmail.com
                mfarron@med.umich.edu
                Journal
                BMC Public Health
                BMC Public Health
                BMC Public Health
                BioMed Central (London )
                1471-2458
                19 December 2019
                19 December 2019
                2019
                : 19
                : 1707
                Affiliations
                [1 ]ISNI 0000000121633745, GRID grid.3575.4, Department of Reproductive Health and Research, World Health Organization, ; Avenue Appia 20, CH-1211 Geneva 27, Switzerland
                [2 ]ISNI 0000000086837370, GRID grid.214458.e, Division of General Medicine, , University of Michigan, ; 2800 Plymouth Road, NCRC, B16/ 400S03, Ann Arbor, USA
                Author information
                http://orcid.org/0000-0001-6949-8976
                Article
                8080
                10.1186/s12889-019-8080-7
                6924003
                31856766
                210300c1-68e2-43a1-8755-ed192be8398d
                © The Author(s). 2019

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 11 March 2019
                : 12 December 2019
                Funding
                Funded by: The UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), a co-sponsored program executed by the WHO, funded this work.
                Categories
                Research Article
                Custom metadata
                © The Author(s) 2019

                Public health
                intrauterine contraceptive device,lng-ius,long acting reversible contraception,policies,family planning

                Comments

                Comment on this article